20n (YC W15), A YC Synthetic Biology Startup, Uses Software To Engineer Microbes For Chemical-Making

by Y Combinator2/26/2015

20n, one of a wave of biotech-related startups that Y Combinator is starting to fund, is the brainchild of a UC Berkeley professor and a post-doc.

Saurabh Srivastava and J. Christopher Anderson have worked together for several years developing software that can design genetically engineered microbes to make specific chemicals. While at their DARPA-backed lab at UC Berkeley, they created bacteria that could produce acetaminophen or Tylenol.

Their special sauce is their software platform. While there are companies that do license out ways to create bacteria that produce specialty chemicals, the process of identifying how to create these microbes is tedious. 20n says its data mining technology can get to 100 times more chemicals than were previously thought possible.”

Read the full story on TechCrunch

Categories

YC News

Author

  • Y Combinator

    Y Combinator created a new model for funding early stage startups. Twice a year we invest a small amount of money ($150k) in a large number of startups (recently 200). The startups move to Silicon